Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.
On August 11, 2026, the Centers for Medicare and Medicaid Services issues a final rule titled, “Prohibition on Federal Medicaid and Children’s Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children” (Final Rule).
The Final Rule prohibits payments to State Medicaid plans for “sex-rejecting procedures” for children under 18 or to a separate Children’s Health Insurance Program (CHIP) for children under 19. Among the definitions included in the Final Rule are:
AMCP and OHMA, are pleased to announce that three Precision Medicine-related articles, co-authored by AMCP and OHMA team members, have been accepted for publication in the Journal of Managed Care & Specialty Pharmacy (JMCP). The articles represent a significant contribution to advancing standardization in how precision medicine is managed across the market access landscape.
On August 10, 2026, President Trump signed an Executive Order titled, Delivering Gold Standard Childhood Vaccine Recommendations for Americans (the EO). The EO recommends all children get immunizations for 11 diseases, a decrease from the 18 diseases recommended by the Centers for Disease Control and Prevention in 2024. The EO states that immunizations that are no longer recommended for all children are now recommended for shared clinical decision-making.
All 50 states have enacted some sort of pharmacy benefit manager (PBM) legislation, but a handful are setting the pace in terms of new laws targeting ownership restrictions, transparency requirements, and compensation models.
AMCP has been honored with a 2026 ASAE Power of Associations Silver Award by the American Society of Association Executives (ASAE) in recognition of its outstanding Patient Voice Initiative, an initiative that demonstrates the powerful role associations play in solving challenges, strengthening industries and professions, and improving communities.
On July 31, 2026, the Health Resources and Services Administration (HRSA) announced (Notice) a revised 340B Rebate Model Pilot Program (Pilot) that would allow participating drug manufacturers to provide 340B discounts through retrospective rebates.
On July 28, 2026, the Centers for Medicare & Medicaid Services (CMS) announced the Calendar Year (CY) 2027 Part D national average monthly bid amount is $296.05, the Part D base beneficiary premium is $41.33, and the de minimis amount is $2.
The Academy of Managed Care Pharmacy (AMCP) thanks the Office of Management and Budget (OMB) for the opportunity to provide comments in response to the proposed rule titled Regulation for Federal Financial Assistance.
